Ida Vind

Ida Vind

Clinical Associate Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2021
  2. Published

    Short and long-term effectiveness and safety of vedolizumab in treatment-refractory patients with ulcerative colitis and Crohn's disease - a real-world two-center cohort study

    Attauabi, M., Vind, Ida, Pedersen, G., Bendtsen, Flemming, Seidelin, Jakob Benedict & Burisch, J., 2021, In: European journal of gastroenterology & hepatology. 33, 15, p. 709-718

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-based Cohort Studies

    Lo, B., Zhao, M., Vind, Ida & Burisch, J., 2021, In: Clinical Gastroenterology and Hepatology. 19, 6, p. 1117-1138.e19 41 p.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort study

    for the NOVA Study Group, F. T. N. S. G., 2021, In: Alimentary Pharmacology and Therapeutics. 54, 10, p. 1320-1329 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 21472222